InnoCare Pharma Limited (OTCMKTS:INCPF) Sees Significant Growth in Short Interest

InnoCare Pharma Limited (OTCMKTS:INCPF) saw a large growth in short interest during the month of February. As of February 27th, there was short interest totaling 2,044,382 shares, a growth of 46.3% from the February 12th total of 1,397,382 shares. Based on an average trading volume of 111 shares, the short-interest ratio is presently 18,417.9 days. Based on an average trading volume of 111 shares, the short-interest ratio is presently 18,417.9 days.

InnoCare Pharma Price Performance

INCPF opened at $1.55 on Monday. The business has a fifty day simple moving average of $1.90 and a 200-day simple moving average of $2.44. InnoCare Pharma has a fifty-two week low of $1.55 and a fifty-two week high of $2.31.

InnoCare Pharma Company Profile

InnoCare Pharma Ltd is a China-based, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule targeted therapies for oncology. Headquartered in Shenzhen, Guangdong Province, the company leverages structure-based drug design and comprehensive preclinical screening to advance drug candidates that address high-unmet-need cancers.

The company’s development pipeline comprises multiple small-molecule inhibitors in various stages of preclinical and early clinical evaluation.